ChristopherDaughertyChristopher Daugherty41.78927490000000-87.60125000000000280Daugherty, ChristopherProfessorprns:coAuthorOfcoauthor ofprns:emailEncryptedemail addressprns:endDateend dateprns:fullNamefull nameprns:grantAwardedBygrant awarded byprns:hasAuthorListauthor listprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:physicalNeighborOfphysical neighborprns:positionInDepartmentposition in departmentprns:predicateNodepredicate nodeprns:principalInvestigatorNameprincipal investigator nameprns:publicationDatepublication dateprns:similarTosimilar toprns:sortOrdersort orderprns:startDatestart dateprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierAddressvivo:addressCitycityvivo:addressPostalCodepostal codevivo:addressStatestate or provinceAgreementvivo:authorInAuthorshipselected publicationsvivo:authorRankauthor rank in publicationAuthorshipDepartmentGrantvivo:hasResearchArearesearch areasvivo:hasResearcherRoleresearch activitiesvivo:hrJobTitleHR job titleInformation Resourcevivo:linkAnchorTextlink anchor textvivo:linkedAuthorlinked authorvivo:linkedInformationResourcelinked information resourcevivo:mailingAddressmailing addressvivo:personInPositionpositionsPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titleResearcher Rolevivo:researcherRoleOfresearcher role ofRolevivo:roleContributesTocontributes tovivo:sponsorAwardIdsponsor award idURLLinkvivo:webpagewebpagerdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPersonAuthorship 10036310Authorship 10059210Authorship 1010533Authorship 1011763Authorship 1015496Authorship 1002281Authorship 1010294Authorship 1001255Authorship 101169227944904Bradbury AR, Daugherty CK, Auh S, Hlubocky FJ, Cummings S, White M, Olopade OIJournal of clinical oncology : official journal of the American Society of Clinical OncologyParental disclosure of genetic test results to young adults, adolescents and children. J Clin Oncol. 2005 Jun; 23(16_suppl):1016.J Clin Oncol2005-06-01T00:00:002005Parental disclosure of genetic test results to young adults, adolescents and children.27945918Hlubocky FJ, Helft PR, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyHope, decision making, and use of the internet and other media among cancer clinical trials participants. J Clin Oncol. 2005 Jun; 23(16_suppl):6068.J Clin Oncol2005-06-01T00:00:002005Hope, decision making, and use of the internet and other media among cancer clinical trials participants.27949814Harding GA, Hlubocky FJ, Siegler M, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyCanadian oncologist communication about prognosis disclosure with their terminally-ill patients. J Clin Oncol. 2008 May 20; 26(15_suppl):6554.J Clin Oncol2008-05-20T00:00:002008Canadian oncologist communication about prognosis disclosure with their terminally-ill patients.26983622Polite BN, Cipriano-Steffens T, Hlubocky F, Dignam J, Ray M, Smith D, Undevia S, Sprague E, Olopade O, Daugherty C, Fitchett G, Gehlert SJournal of racial and ethnic health disparitiesAn Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population. J Racial Ethn Health Disparities. 2017 04; 4(2):140-148.J Racial Ethn Health Disparities2016-03-16T00:00:002016An Evaluation of Psychosocial and Religious Belief Differences in a Diverse Racial and Socioeconomic Urban Cancer Population.27948232Hlubocky FJ, Larson E, Sachs G, Lesniak MS, Ratain MJ, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyA study of informed consent (IC), age, and cognitive performance (CP) among advanced cancer patients (acp) in phase I trials. J Clin Oncol. 2008 May 20; 26(15_suppl):9523.J Clin Oncol2008-05-20T00:00:002008A study of informed consent (IC), age, and cognitive performance (CP) among advanced cancer patients (acp) in phase I trials.27233054Dunn LB, Wiley J, Garrett S, Hlubocky F, Daugherty C, Trupin L, Munster P, Dohan DPsycho-oncologyInterest in initiating an early phase clinical trial: results of a longitudinal study of advanced cancer patients. Psychooncology. 2017 Oct; 26(10):1604-1610.Psychooncology2016-06-20T00:00:002016Interest in initiating an early phase clinical trial: results of a longitudinal study of advanced cancer patients.27947041Teitelbaum UR, Hlubocky FJ, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologySurvival and informed consent understanding of elderly advanced cancer patients enrolling in phase I trials. J Clin Oncol. 2005 Jun; 23(16_suppl):8109.J Clin Oncol2005-06-01T00:00:002005Survival and informed consent understanding of elderly advanced cancer patients enrolling in phase I trials.27949371Daugherty CK, Spill G, Siegler M, Hlubocky FJJournal of clinical oncology : official journal of the American Society of Clinical OncologyOncologists and physiatrists attitudes regarding rehabilitation for patients with advanced cancer. J Clin Oncol. 2008 May 20; 26(15_suppl):6623.J Clin Oncol2008-05-20T00:00:002008Oncologists and physiatrists attitudes regarding rehabilitation for patients with advanced cancer.27948352Bradbury AR, Patrick-Miller L, Feigon M, Pawlowski K, Egleston B, Ibe C, Sands CB, Cummings S, Olopade OI, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyShould genetic testing for BRCA1/2 be permitted for minors? Opinions of parents who completed BRCA1/2 testing. J Clin Oncol. 2008 May 20; 26(15_suppl):1511.J Clin Oncol2008-05-20T00:00:002008Should genetic testing for BRCA1/2 be permitted for minors? Opinions of parents who completed BRCA1/2 testing.Authorship 104171528488050Garrett SB, Koenig CJ, Trupin L, Hlubocky FJ, Daugherty CK, Reinert A, Munster P, Dohan DSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerWhat advanced cancer patients with limited treatment options know about clinical research: a qualitative study. Support Care Cancer. 2017 10; 25(10):3235-3242.Support Care Cancer2017-05-09T00:00:002017What advanced cancer patients with limited treatment options know about clinical research: a qualitative study.VijayaRaoVijaya Rao41.7886000000000087.598699999999993538Rao, VijayaAssistant ProfessorMedicine-GastroenterologyMedicine-General Internal MedicineD003657Physiology2406410.649156Decision MakingAuthorship 11594110Authorship 1184687Authorship 1249459Authorship 121794229985748Hlubocky FJ, Sachs GA, Larson ER, Nimeiri HS, Cella D, Wroblewski KE, Ratain MJ, Peppercorn JM, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyDo Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials? J Clin Oncol. 2018 08 20; 36(24):2483-2491.J Clin Oncol2018-07-09T00:00:002018Do Patients With Advanced Cancer Have the Ability to Make Informed Decisions for Participation in Phase I Clinical Trials?29365323Drazer MW, Kadri S, Sukhanova M, Patil SA, West AH, Feurstein S, Calderon DA, Jones MF, Weipert CM, Daugherty CK, Ceballos-López AA, Raca G, Lingen MW, Li Z, Segal JP, Churpek JE, Godley LABlood advancesPrognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies. Blood Adv. 2018 01 23; 2(2):146-150.Blood Adv2018-01-23T00:00:002018Prognostic tumor sequencing panels frequently identify germ line variants associated with hereditary hematopoietic malignancies.29787333Hlubocky FJ, Kass NE, Roter D, Larson S, Wroblewski KE, Sugarman J, Daugherty CKJournal of oncology practiceInvestigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials. J Oncol Pract. 2018 06; 14(6):e357-e367.J Oncol Pract2018-05-22T00:00:002018Investigator Disclosure and Advanced Cancer Patient Understanding of Informed Consent and Prognosis in Phase I Clinical Trials.30433849Hlubocky FJ, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyReply to J. Schildmann et al. J Clin Oncol. 2019 01 10; 37(2):170-171.J Clin Oncol2018-11-15T00:00:002018Reply to J. Schildmann et al.Authorship 100623Authorship 127641Authorship 121633Authorship 128618530907925Hantel A, Siegler M, Hlubocky F, Colgan K, Daugherty CKJAMA internal medicinePrevalence and Severity of Rationing During Drug Shortages: A National Survey of Health System Pharmacists. JAMA Intern Med. 2019 05 01; 179(5):710-711.JAMA Intern Med2019-05-01T00:00:002019Prevalence and Severity of Rationing During Drug Shortages: A National Survey of Health System Pharmacists.Authorship 160161Authorship 134871Authorship 149111Authorship 129297231041005Rao VL, Daugherty CClinical liver diseaseIs it ethical to enroll a patient in a hepatitis C virus clinical trial when current standard of care is highly effective and safe? Clin Liver Dis (Hoboken). 2015 Nov; 6(5):120-121.Clin Liver Dis (Hoboken)2015-12-09T00:00:002015Is it ethical to enroll a patient in a hepatitis C virus clinical trial when current standard of care is highly effective and safe?Authorship 169501Authorship 139582Authorship 196911Authorship 191492Authorship 190172Authorship 221283Authorship 212351Authorship 246281Authorship 255096Authorship 326834Authorship 314524Authorship 256271Authorship 133543631603726Garrett SB, Matthews TM, Abramson CM, Koenig CJ, Hlubocky FJ, Daugherty CK, Munster PN, Dohan DJCO oncology practiceBefore Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials. JCO Oncol Pract. 2020 01; 16(1):e56-e63.JCO Oncol Pract2019-10-11T00:00:002019Before Consent: Qualitative Analysis of Deliberations of Patients With Advanced Cancer About Early-Phase Clinical Trials.Authorship 329694Authorship 340287Authorship 3025811Authorship 307022Authorship 4165015Authorship 401335Authorship 327429Authorship 328103Authorship 4157410Authorship 135012231873980Strohbehn GW, Daugherty CKThe oncologistMistaking the Trees for the Forest? Oncologist. 2020 04; 25(4):e743.Oncologist2019-12-24T00:00:002019Mistaking the Trees for the Forest?Authorship 341331Authorship 351785Authorship 1355881232031887Temel JS, Sloan J, Zemla T, Greer JA, Jackson VA, El-Jawahri A, Kamdar M, Kamal A, Blinderman CD, Strand J, Zylla D, Daugherty C, Furqan M, Obel J, Razaq M, Roeland EJ, Loprinzi CJournal of palliative medicineMultisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303. J Palliat Med. 2020 07; 23(7):922-929.J Palliat Med2020-02-07T00:00:002020Multisite, Randomized Trial of Early Integrated Palliative and Oncology Care in Patients with Advanced Lung and Gastrointestinal Cancer: Alliance A221303.Authorship 136055832089792Hantel A, Egan AM, Nguyen TT, DeMartino ES, Hlubocky F, Bastow S, Siegler M, Daugherty CKJournal of graduate medical educationA Cross-Sectional Survey of Medical Trainee Experiences During Medication Shortages. J Grad Med Educ. 2020 Feb; 12(1):38-43.J Grad Med Educ2020-02-01T00:00:002020A Cross-Sectional Survey of Medical Trainee Experiences During Medication Shortages.Authorship 384576Authorship 91251Authorship 426973Authorship 460899Authorship 137894432469685Hantel A, Hlubocky FJ, Siegler M, Daugherty CKJCO oncology practiceA Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed. JCO Oncol Pract. 2020 10; 16(10):e1098-e1111.JCO Oncol Pract2020-05-29T00:00:002020A Qualitative Analysis of Oncology Patient Awareness of Medication Shortages and Their Preferences for How Shortages Should Be Managed.Authorship 480506Authorship 94381Authorship 169111Authorship 173582Authorship 194503Authorship 207171Authorship 225911Authorship 227872Authorship 230004D007258Concepts & IdeasProcedures842660.806043Informed ConsentAuthorship 2745313Authorship 275724Authorship 279081Authorship 358258Authorship 367151Authorship 477563D017321Activities & BehaviorsProcedures631550.91097Clinical Trials, Phase I as TopicAuthorship 604078680997Sharma L, Sinacore J, Daugherty C, Kuesis DT, Stulberg SD, Lewis M, Baumann G, Chang RWThe journals of gerontology. Series A, Biological sciences and medical sciencesPrognostic factors for functional outcome of total knee replacement: a prospective study. J Gerontol A Biol Sci Med Sci. 1996 Jul; 51(4):M152-7.J Gerontol A Biol Sci Med Sci1996-07-01T00:00:001996Prognostic factors for functional outcome of total knee replacement: a prospective study.8891704Daugherty CK, Geller GThe Hastings Center reportHope and the limits of research. Hastings Cent Rep. 1996 Sep-Oct; 26(5):20; discussion 20-2.Hastings Cent Rep1996-09-01T00:00:001996Hope and the limits of research.9163291Daugherty CK, Siegler M, Ratain MJ, Zimmer GAnnals of internal medicineLearning from our patients: one participant's impact on clinical trial research and informed consent. Ann Intern Med. 1997 Jun 01; 126(11):892-7.Ann Intern Med1997-06-01T00:00:001997Learning from our patients: one participant's impact on clinical trial research and informed consent.9667244Daugherty CK, Ratain MJ, Minami H, Banik DM, Vogelzang NJ, Stadler WM, Siegler MJournal of clinical oncology : official journal of the American Society of Clinical OncologyStudy of cohort-specific consent and patient control in phase I cancer trials. J Clin Oncol. 1998 Jul; 16(7):2305-12.J Clin Oncol1998-07-01T00:00:001998Study of cohort-specific consent and patient control in phase I cancer trials.10334550Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyImpact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective. J Clin Oncol. 1999 May; 17(5):1601-17.J Clin Oncol1999-05-01T00:00:001999Impact of therapeutic research on informed consent and the ethics of clinical trials: a medical oncology perspective.10638485Daugherty CKInvestigational new drugsEthical issues in the development of new agents. Invest New Drugs. 1999; 17(2):145-53.Invest New Drugs1999-01-01T00:00:001999Ethical issues in the development of new agents.9339751Dann EJ, Daugherty CK, Larson RABone marrow transplantationAllogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma. Bone Marrow Transplant. 1997 Sep; 20(5):369-74.Bone Marrow Transplant1997-09-01T00:00:001997Allogeneic bone marrow transplantation for relapsed and refractory Hodgkin's disease and non-Hodgkin's lymphoma.11697385Daugherty CK, Banik DM, Janish L, Ratain MJIRBQuantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients. IRB. 2000 May-Jun; 22(3):6-14.IRB2000-05-01T00:00:002000Quantitative analysis of ethical issues in phase I trials: a survey interview of 144 advanced cancer patients.10808200Sobecks RM, Daugherty CK, Hallahan DE, Laport GF, Wagner ND, Larson RABone marrow transplantationA dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies. Bone Marrow Transplant. 2000 Apr; 25(8):807-13.Bone Marrow Transplant2000-04-01T00:00:002000A dose escalation study of total body irradiation followed by high-dose etoposide and allogeneic blood stem cell transplantation for the treatment of advanced hematologic malignancies.10650482Daugherty CKCancer treatment and researchInformed consent, the cancer patient, and phase I clinical trials. Cancer Treat Res. 2000; 102:77-89.Cancer Treat Res2000-01-01T00:00:002000Informed consent, the cancer patient, and phase I clinical trials.11551029Siston AK, List MA, Daugherty CK, Banik DM, Menke C, Cornetta K, Larson RABone marrow transplantationPsychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation. Bone Marrow Transplant. 2001 Jun; 27(11):1181-8.Bone Marrow Transplant2001-06-01T00:00:002001Psychosocial adjustment of patients and caregivers prior to allogeneic bone marrow transplantation.11378542Cataland SR, Daugherty CK, Weseman EC, Larson RALeukemia & lymphomaPreliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia. Leuk Lymphoma. 2001 Apr; 41(3-4):297-307.Leuk Lymphoma2001-04-01T00:00:002001Preliminary experience with a new chemotherapy regimen for adults with acute lymphoblastic leukemia.11428154Gordon EJ, Daugherty CKThe Journal of clinical ethicsReferral and decision making among advanced cancer patients participating in Phase I trials at a single institution. J Clin Ethics. 2001; 12(1):31-8.J Clin Ethics2001-01-01T00:00:002001Referral and decision making among advanced cancer patients participating in Phase I trials at a single institution.12812182Gordon EJ, Daugherty CKBioethics'Hitting you over the head': oncologists' disclosure of prognosis to advanced cancer patients. Bioethics. 2003 Apr; 17(2):142-68.Bioethics2003-04-01T00:00:002003'Hitting you over the head': oncologists' disclosure of prognosis to advanced cancer patients.12883963Helft PR, Hlubocky F, Wen M, Daugherty CKSupportive care in cancer : official journal of the Multinational Association of Supportive Care in CancerAssociations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trials. Support Care Cancer. 2003 Oct; 11(10):644-51.Support Care Cancer2003-07-12T00:00:002003Associations among awareness of prognosis, hopefulness, and coping in patients with advanced cancer participating in phase I clinical trials.12610198Helft PR, Hlubocky F, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyAmerican oncologists' views of internet use by cancer patients: a mail survey of American Society of Clinical Oncology members. J Clin Oncol. 2003 Mar 01; 21(5):942-7.J Clin Oncol2003-03-01T00:00:002003American oncologists' views of internet use by cancer patients: a mail survey of American Society of Clinical Oncology members.15069770Daugherty CKCancer investigationExamining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patients. Cancer Invest. 2004; 22(1):123-31.Cancer Invest2004-01-01T00:00:002004Examining ethical dilemmas as obstacles to hospice and palliative care for advanced cancer patients.12039940Daugherty CK, Steensma DPJournal of clinical oncology : official journal of the American Society of Clinical OncologyOvercoming obstacles to hospice care: an ethical examination of inertia and inaction. J Clin Oncol. 2002 Jun 01; 20(11):2752-5.J Clin Oncol2002-06-01T00:00:002002Overcoming obstacles to hospice care: an ethical examination of inertia and inaction.12228195Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyThe "cure" for cancer: can the media report the hope without the hype? J Clin Oncol. 2002 Sep 15; 20(18):3761-4.J Clin Oncol2002-09-15T00:00:002002The "cure" for cancer: can the media report the hope without the hype?15349753Odenike OM, Sobecks RM, Janisch L, Huo D, Zimmerman TM, Daugherty CK, Ratain MJ, Larson RACancer chemotherapy and pharmacologyA phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases. Cancer Chemother Pharmacol. 2004 Dec; 54(6):553-61.Cancer Chemother Pharmacol2004-09-02T00:00:002004A phase I trial of gemcitabine plus cladribine in patients with advanced hematologic malignant diseases.12743190Daugherty CK, Steensma DPJournal of clinical oncology : official journal of the American Society of Clinical OncologyOvercoming obstacles to hospice care: an ethical examination of inertia and inaction. J Clin Oncol. 2003 May 01; 21(9 Suppl):42s-45s.J Clin Oncol2003-05-01T00:00:002003Overcoming obstacles to hospice care: an ethical examination of inertia and inaction.Medicine-Hematology and OncologyPediatrics-Academic Pediatrics17704419Bradbury AR, Dignam JJ, Ibe CN, Auh SL, Hlubocky FJ, Cummings SA, White M, Olopade OI, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyHow often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults. J Clin Oncol. 2007 Aug 20; 25(24):3705-11.J Clin Oncol2007-08-20T00:00:002007How often do BRCA mutation carriers tell their young children of the family's risk for cancer? A study of parental disclosure of BRCA mutations to minors and young adults.17724946Vohra PD, Johnson JK, Daugherty CK, Wen M, Barach PJoint Commission journal on quality and patient safetyHousestaff and medical student attitudes toward medical errors and adverse events. Jt Comm J Qual Patient Saf. 2007 Aug; 33(8):493-501.Jt Comm J Qual Patient Saf2007-08-01T00:00:002007Housestaff and medical student attitudes toward medical errors and adverse events.Authorship 14409016Authorship 144214633555934Hlubocky FJ, Symington BE, McFarland DC, Gallagher CM, Dragnev KH, Burke JM, Lee RT, El-Jawahri A, Popp B, Rosenberg AR, Thompson MA, Dizon DS, Srivastava P, Patel MI, Kamal AH, Daugherty CK, Back AL, Dokucu ME, Shanafelt TDJCO oncology practiceImpact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization's Response for Readiness, Mitigation, and Resilience. JCO Oncol Pract. 2021 07; 17(7):365-374.JCO Oncol Pract2021-02-08T00:00:002021Impact of the COVID-19 Pandemic on Oncologist Burnout, Emotional Well-Being, and Moral Distress: Considerations for the Cancer Organization's Response for Readiness, Mitigation, and Resilience.33567241Hlubocky FJ, Sher TG, Cella D, Wroblewski KE, Peppercorn J, Daugherty CKJCO oncology practiceAnxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers. JCO Oncol Pract. 2021 02; 17(2):e101-e110.JCO Oncol Pract2021-02-01T00:00:002021Anxiety Shapes Expectations of Therapeutic Benefit in Phase I Trials for Patients With Advanced Cancer and Spousal Caregivers.17846595Pollyea DA, Artz AS, Stock W, Daugherty C, Godley L, Odenike OM, Rich E, Smith SM, Zimmerman T, Zhang Y, Huo D, Larson R, van Besien KBone marrow transplantationOutcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation. Bone Marrow Transplant. 2007 Dec; 40(11):1027-32.Bone Marrow Transplant2007-09-10T00:00:002007Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation.19029419Daugherty CK, Hlubocky FJJournal of clinical oncology : official journal of the American Society of Clinical OncologyWhat are terminally ill cancer patients told about their expected deaths? A study of cancer physicians' self-reports of prognosis disclosure. J Clin Oncol. 2008 Dec 20; 26(36):5988-93.J Clin Oncol2008-11-24T00:00:002008What are terminally ill cancer patients told about their expected deaths? A study of cancer physicians' self-reports of prognosis disclosure.15386780Daugherty CK, Fitchett G, Murphy PE, Peterman AH, Banik DM, Hlubocky F, Tartaro JPsycho-oncologyTrusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents. Psychooncology. 2005 Feb; 14(2):135-46.Psychooncology2005-02-01T00:00:002005Trusting God and medicine: spirituality in advanced cancer patients volunteering for clinical trials of experimental agents.18702049Bradbury AR, Patrick-Miller L, Pawlowski K, Ibe CN, Cummings SA, Hlubocky F, Olopade OI, Daugherty CKPsycho-oncologyLearning of your parent's BRCA mutation during adolescence or early adulthood: a study of offspring experiences. Psychooncology. 2009 Feb; 18(2):200-8.Psychooncology2009-02-01T00:00:002009Learning of your parent's BRCA mutation during adolescence or early adulthood: a study of offspring experiences.16051948Helft PR, Eckles RE, Johnson-Calley CS, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyUse of the internet to obtain cancer information among cancer patients at an urban county hospital. J Clin Oncol. 2005 Aug 01; 23(22):4954-62.J Clin Oncol2005-08-01T00:00:002005Use of the internet to obtain cancer information among cancer patients at an urban county hospital.16920562Artz AS, Pollyea DA, Kocherginsky M, Stock W, Rich E, Odenike O, Zimmerman T, Smith S, Godley L, Thirman M, Daugherty C, Extermann M, Larson R, van Besien KBiology of blood and marrow transplantation : journal of the American Society for Blood and Marrow TransplantationPerformance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2006 Sep; 12(9):954-64.Biol Blood Marrow Transplant2006-09-01T00:00:002006Performance status and comorbidity predict transplant-related mortality after allogeneic hematopoietic cell transplantation.D008495Occupations1263570.742839Medical Oncology20536346Godley LA, Njiaju UO, Green M, Weiner H, Lin S, Odenike O, Rich ES, Artz A, Van Besien K, Daugherty CK, Zhang Y, Le Beau MM, Stock W, Larson RALeukemia & lymphomaTreatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant. Leuk Lymphoma. 2010 Jun; 51(6):995-1006.Leuk Lymphoma2010-06-01T00:00:002010Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant.17290064Hlubocky FJ, Ratain MJ, Wen M, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyComplementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making. J Clin Oncol. 2007 Feb 10; 25(5):548-54.J Clin Oncol2007-02-10T00:00:002007Complementary and alternative medicine among advanced cancer patients enrolled on phase I trials: a study of prognosis, quality of life, and preferences for decision making.17687154Gray SW, Hlubocky FJ, Ratain MJ, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyAttitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials. J Clin Oncol. 2007 Aug 10; 25(23):3488-94.J Clin Oncol2007-08-10T00:00:002007Attitudes toward research participation and investigator conflicts of interest among advanced cancer patients participating in early phase clinical trials.18505899Lee RT, Hlubocky FJ, Hu JJ, Stafford RS, Daugherty CKIntegrative cancer therapiesAn international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM). Integr Cancer Ther. 2008 Jun; 7(2):70-5.Integr Cancer Ther2008-05-27T00:00:002008An international pilot study of oncology physicians' opinions and practices on Complementary and Alternative Medicine (CAM).21913806Larson SM, Campbell NP, Huo D, Artz A, Zhang Y, Gajria D, Green M, Weiner H, Daugherty C, Odenike O, Godley LA, Hyjek E, Gurbuxani S, Thirman M, Sipkins D, Van Besien K, Larson RA, Stock WLeukemia & lymphomaHigh dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML). Leuk Lymphoma. 2012 Mar; 53(3):445-50.Leuk Lymphoma2012-03-01T00:00:002012High dose cytarabine and mitoxantrone: an effective induction regimen for high-risk acute myeloid leukemia (AML).18200524Bradbury AR, Patrick-Miller L, Pawlowski K, Ibe CN, Cummings SA, Olopade OI, Daugherty CKAmerican journal of medical genetics. Part C, Seminars in medical geneticsShould genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring. Am J Med Genet C Semin Med Genet. 2008 Feb 15; 148C(1):70-7.Am J Med Genet C Semin Med Genet2008-02-15T00:00:002008Should genetic testing for BRCA1/2 be permitted for minors? Opinions of BRCA mutation carriers and their adult offspring.18227527Daugherty CK, Ratain MJ, Emanuel EJ, Farrell AT, Schilsky RLJournal of clinical oncology : official journal of the American Society of Clinical OncologyEthical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials. J Clin Oncol. 2008 Mar 10; 26(8):1371-8.J Clin Oncol2008-01-28T00:00:002008Ethical, scientific, and regulatory perspectives regarding the use of placebos in cancer clinical trials.20038717Henderson TO, Hlubocky FJ, Wroblewski KE, Diller L, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyPhysician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists. J Clin Oncol. 2010 Feb 10; 28(5):878-83.J Clin Oncol2009-12-28T00:00:002009Physician preferences and knowledge gaps regarding the care of childhood cancer survivors: a mailed survey of pediatric oncologists.16163205Daugherty CKClinical advances in hematology & oncology : H&OEthical issues in phase I clinical trials. Clin Adv Hematol Oncol. 2004 Jun; 2(6):358-60.Clin Adv Hematol Oncol2004-06-01T00:00:002004Ethical issues in phase I clinical trials.22231763Bradbury AR, Patrick-Miller L, Egleston BL, Olopade OI, Daly MB, Moore CW, Sands CB, Schmidheiser H, Kondamudi PK, Feigon M, Ibe CN, Daugherty CKCancerWhen parents disclose BRCA1/2 test results: their communication and perceptions of offspring response. Cancer. 2012 Jul 01; 118(13):3417-25.Cancer2012-01-09T00:00:002012When parents disclose BRCA1/2 test results: their communication and perceptions of offspring response.22457322Ishida Y, Takahashi M, Maru M, Mori M, Henderson TO, Daugherty CK, Manabe AJapanese journal of clinical oncologyPhysician preferences and knowledge regarding the care of childhood cancer survivors in Japan: a mailed survey of the Japanese Society of Pediatric Oncology. Jpn J Clin Oncol. 2012 Jun; 42(6):513-21.Jpn J Clin Oncol2012-03-28T00:00:002012Physician preferences and knowledge regarding the care of childhood cancer survivors in Japan: a mailed survey of the Japanese Society of Pediatric Oncology.3918212Greenberger JS, Palaszynski EW, Pierce JH, Sakakeeny MA, Ruscetti SK, Ihle JN, Daugherty CJournal of the National Cancer InstituteBiologic effects of prolonged melphalan treatment of murine long-term bone marrow cultures and interleukin 3-dependent hematopoietic progenitor cell lines. J Natl Cancer Inst. 1985 Jan; 74(1):247-62.J Natl Cancer Inst1985-01-01T00:00:001985Biologic effects of prolonged melphalan treatment of murine long-term bone marrow cultures and interleukin 3-dependent hematopoietic progenitor cell lines.7619746Daugherty CK, Ratain MJ, Siegler MAnnals of oncology : official journal of the European Society for Medical OncologyPushing the envelope: informed consent in phase I trials. Ann Oncol. 1995 Apr; 6(4):321-3.Ann Oncol1995-04-01T00:00:001995Pushing the envelope: informed consent in phase I trials.19552233Kass NE, Sugarman J, Medley AM, Fogarty LA, Taylor HA, Daugherty CK, Emerson MR, Goodman SN, Hlubocky FJ, Hurwitz HI, Carducci M, Goodwin-Landher AIRBAn intervention to improve cancer patients' understanding of early-phase clinical trials. IRB. 2009 May-Jun; 31(3):1-10.IRB2009-05-01T00:00:002009An intervention to improve cancer patients' understanding of early-phase clinical trials.20890139Zafar SY, Currow DC, Daugherty CK, Abernethy APCancer journal (Sudbury, Mass.)Standards for palliative care delivery in oncology settings. Cancer J. 2010 Sep-Oct; 16(5):436-43.Cancer J2010-09-01T00:00:002010Standards for palliative care delivery in oncology settings.7738612Daugherty C, Ratain MJ, Grochowski E, Stocking C, Kodish E, Mick R, Siegler MJournal of clinical oncology : official journal of the American Society of Clinical OncologyPerceptions of cancer patients and their physicians involved in phase I trials. J Clin Oncol. 1995 May; 13(5):1062-72.J Clin Oncol1995-05-01T00:00:001995Perceptions of cancer patients and their physicians involved in phase I trials.7966396Mick R, Lane N, Daugherty C, Ratain MJJournal of the National Cancer InstitutePhysician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials. J Natl Cancer Inst. 1994 Nov 16; 86(22):1685-93.J Natl Cancer Inst1994-11-16T00:00:001994Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials.16009946van Besien K, Artz A, Smith S, Cao D, Rich S, Godley L, Jones D, Del Cerro P, Bennett D, Casey B, Odenike O, Thirman M, Daugherty C, Wickrema A, Zimmerman T, Larson RA, Stock WJournal of clinical oncology : official journal of the American Society of Clinical OncologyFludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome. J Clin Oncol. 2005 Aug 20; 23(24):5728-38.J Clin Oncol2005-07-11T00:00:002005Fludarabine, melphalan, and alemtuzumab conditioning in adults with standard-risk advanced acute myeloid leukemia and myelodysplastic syndrome.17050863Helft PR, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyAre we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation. J Clin Oncol. 2006 Oct 20; 24(30):4793-5.J Clin Oncol2006-10-20T00:00:002006Are we taking without giving in return? The ethics of research-related biopsies and the benefits of clinical trial participation.20567018Bradbury AR, Patrick-Miller L, Egleston B, Sands CB, Li T, Schmidheiser H, Feigon M, Ibe CN, Hlubocky FJ, Hope K, Jackson S, Corbman M, Olopade OI, Daly M, Daugherty CKJournal of clinical oncology : official journal of the American Society of Clinical OncologyParent opinions regarding the genetic testing of minors for BRCA1/2. J Clin Oncol. 2010 Jul 20; 28(21):3498-505.J Clin Oncol2010-06-21T00:00:002010Parent opinions regarding the genetic testing of minors for BRCA1/2.22373458Spill GR, Hlubocky FJ, Daugherty CKPM & R : the journal of injury, function, and rehabilitationOncologists' and physiatrists' attitudes regarding rehabilitation for patients with advanced cancer. PM R. 2012 Feb; 4(2):96-108.PM R2012-02-01T00:00:002012Oncologists' and physiatrists' attitudes regarding rehabilitation for patients with advanced cancer.36655425Roloff GW, Wen F, Ramsland A, Artz AS, Kosuri S, Stock W, Odenike O, Larson RA, Liu H, Godley LA, Thirman MJ, Patel AA, Daugherty CK, DuVall AS, Nawas MT, Dworkin E, Wool GD, Gurbuxani S, Fitzpatrick C, Segal JP, Wang P, Drazer MWHaematologicaClinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors. Haematologica. 2023 08 01; 108(8):2234-2239.Haematologica2023-08-01T00:00:002023Clinical and molecular response of acute myeloid leukemia harboring non-canonical FLT3 N676K driver mutations to contemporary FLT3 inhibitors.35985004Hlubocky FJ, Daugherty CK, Peppercorn J, Young K, Wroblewski KE, Yamada SD, Lee NKJCO clinical cancer informaticsUtilization of an Electronic Patient-Reported Outcome Platform to Evaluate the Psychosocial and Quality-of-Life Experience Among a Community Sample of Ovarian Cancer Survivors. JCO Clin Cancer Inform. 2022 08; 6:e2200035.JCO Clin Cancer Inform2022-08-01T00:00:002022Utilization of an Electronic Patient-Reported Outcome Platform to Evaluate the Psychosocial and Quality-of-Life Experience Among a Community Sample of Ovarian Cancer Survivors.https://cgh.uchicago.edu/page/leadershipGlobal Healthhttps://www.uchicagomedicine.org/find-a-physician/physician/olufunmilayo-i-olopadeUChicago Medicinehttps://cancerbio.uchicago.edu/program/faculty/olufunmilayo-olopadeCancer Biologyhttps://www.uchicagomedicine.org/conditions-services/cancer/cancer-risk-preventionCancer Risk and Preventionhttp://www.pgrn.org/pgx-of-chemotherapeutic-toxicities.htmlMy Lab Objectiveshttps://klinelab.uchicago.edu/My Lab Site2012-04-30NIHDAUGHERTY, CHRISTOPHER K2000-07-01Ethics and Clinical Trials in Advanced Cancer CareR01CA087605Principal InvestigatorD009369Disorders55628890.338498NeoplasmsAuthorship 1648832Authorship 16487313MedicinePediatricsUniversity of ChicagoYonglanZhengYonglan Zheng41.78927490000000-87.601250000000001374Zheng, YonglanResearch Associate ProfessorMark J.RatainMark J. Ratain41.78927490000000-87.601250000000001401Ratain, Mark J.ProfessorWendyStockwHF9BKIeOfnamXNnYUHhvWD+6g==Wendy Stock41.78927490000000-87.601250000000001502Stock, WendyProfessorLainieRoss23BmGLI1DO/RmHllZ0mg9mHvLainie Ross41.78927490000000-87.601250000000001639Ross, LainieProfessorGiniFleming0GRlDqwcF+v5hHlsaUXv9Gq0+s+oGini Fleming41.78927490000000-87.601250000000001804Fleming, GiniProfessorMarkSieglerMark Siegler41.78927490000000-87.601250000000001868Siegler, MarkProfessorJustin P.Kline3WllAq8QOfnamXNnYUHhvWD+6g==Justin P. Kline41.78927490000000-87.601250000000001922Kline, Justin P.ProfessorOlufunmilayoOlopade321vBIF1GuTQkntjbwjr93A=Olufunmilayo Olopade41.78927490000000-87.601250000000001960Olopade, OlufunmilayoProfessorRichardSchilskyRichard Schilsky41.78927490000000-87.601250000000002119Schilsky, RichardProfessor EmeritusMary EileenDolan2mdtBK0UF8zMknJtY0fp/Cv/+94=Mary Eileen Dolan41.78927490000000-87.601250000000002594Dolan, Mary EileenProfessor4.00680.00271908345research areas1.173120.017079437coauthor of117.63416.082960similar to1184selected publicationsTara O.HendersonTara O. Henderson41.78927490000000-87.60125000000000406Henderson, Tara O.ProfessorDanielSulmasyDaniel Sulmasy41.78927490000000-87.6012500000000067Sulmasy, DanielEmeritus/Emerita, Professortrue1Emeritus/Emerita, ProfessorEmeritus/Emerita, Professortrue1Professor EmeritusProfessor Emeritustrue1Assistant ProfessorAssistant Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1Research Associate ProfessorResearch Associate Professortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorAuthorship 653442Authorship 665877Authorship 744612Authorship 723224Authorship 76922523471729Nathan PC, Daugherty CK, Wroblewski KE, Kigin ML, Stewart TV, Hlubocky FJ, Grunfeld E, Del Giudice ME, Ward LA, Galliher JM, Oeffinger KC, Henderson TOJournal of cancer survivorship : research and practiceFamily physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer. J Cancer Surviv. 2013 Sep; 7(3):275-82.J Cancer Surviv2013-03-08T00:00:002013Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer.24573662Suh E, Daugherty CK, Wroblewski K, Lee H, Kigin ML, Rasinski KA, Ford JS, Tonorezos ES, Nathan PC, Oeffinger KC, Henderson TOAnnals of internal medicineGeneral internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey. Ann Intern Med. 2014 Jan 07; 160(1):11-7.Ann Intern Med2014-01-07T00:00:002014General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey.24954526de Souza JA, Yap BJ, Hlubocky FJ, Wroblewski K, Ratain MJ, Cella D, Daugherty CKCancerThe development of a financial toxicity patient-reported outcome in cancer: The COST measure. Cancer. 2014 Oct 15; 120(20):3245-53.Cancer2014-06-20T00:00:002014The development of a financial toxicity patient-reported outcome in cancer: The COST measure.24845866Harris D, Patrick-Miller L, Schwartz L, Lantos J, Daugherty C, Daly M, Andrulis IL, Buys SS, Chung WK, Frost CJ, John EM, Keegan TH, Knight JA, Terry MB, Bradbury ARThe Journal of adolescent health : official publication of the Society for Adolescent MedicineHuman subjects protection: an event monitoring committee for research studies of girls from breast cancer families. J Adolesc Health. 2014 Sep; 55(3):352-7.J Adolesc Health2014-05-17T00:00:002014Human subjects protection: an event monitoring committee for research studies of girls from breast cancer families.25732158de Souza JA, Yap B, Ratain MJ, Daugherty CJournal of clinical oncology : official journal of the American Society of Clinical OncologyUser beware: we need more science and less art when measuring financial toxicity in oncology. J Clin Oncol. 2015 Apr 20; 33(12):1414-5.J Clin Oncol2015-03-02T00:00:002015User beware: we need more science and less art when measuring financial toxicity in oncology.Chicago60637ILAuthorship 87558926749023Muffly LS, Hlubocky FJ, Khan N, Wroblewski K, Breitenbach K, Gomez J, McNeer JL, Stock W, Daugherty CKCancerPsychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship. Cancer. 2016 Mar 15; 122(6):954-61.Cancer2016-01-07T00:00:002016Psychological morbidities in adolescent and young adult blood cancer patients during curative-intent therapy and early survivorship.Authorship 513154Authorship 5328611Authorship 59675123943994FitzGerald TJ, McKenna M, Kase K, Daugherty C, Rothstein L, Greenberger JSInternational journal of radiation oncology, biology, physicsEffect of X-irradiation dose rate on the clonagenic survival of human and experimental animal hematopoietic tumor cell lines: evidence for heterogeneity. Int J Radiat Oncol Biol Phys. 1986 Jan; 12(1):69-73.Int J Radiat Oncol Biol Phys1986-01-01T00:00:001986Effect of X-irradiation dose rate on the clonagenic survival of human and experimental animal hematopoietic tumor cell lines: evidence for heterogeneity.9709937Miller K, Corcoran C, Armstrong C, Caramelli K, Anderson E, Cotton D, Basgoz N, Hirschhorn L, Tuomala R, Schoenfeld D, Daugherty C, Mazer N, Grinspoon SThe Journal of clinical endocrinology and metabolismTransdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study. J Clin Endocrinol Metab. 1998 Aug; 83(8):2717-25.J Clin Endocrinol Metab1998-08-01T00:00:001998Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: a pilot study.Authorship 955381027716900de Souza JA, Yap BJ, Wroblewski K, Blinder V, Araújo FS, Hlubocky FJ, Nicholas LH, O'Connor JM, Brockstein B, Ratain MJ, Daugherty CK, Cella DCancerMeasuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017 02 01; 123(3):476-484.Cancer2016-10-07T00:00:002016Measuring financial toxicity as a clinically relevant patient-reported outcome: The validation of the COmprehensive Score for financial Toxicity (COST).